FeesSafety
Pluang+

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

Market News
29 Oct 2026, 07:00 WIB
Luxeed International
View Source
Bullish
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 185 km drive covering highways and mountain roads to evaluate the vehicles' smart technology, comfort, and handling. The event highlighted advanced features like the NOA driving assist, dual-chamber air suspension, and continuous damping control, impressing attendees with Stormax's performance. This program builds anticipation for the models' market launch next year.

LUXEED's global media test drive event provides context for the Consumer Cyclical sector's performance on Pluang as of Oct 29, 2026 05:32 WIB. Among 134 priced US stocks in this sector, 66 rose and 67 fell. Notable movers include CAVA Group Inc, which gained 5.26% with a nearly balanced sell/buy order activity, contrasting with Smurfit WestRock plc and Chewy Inc, which declined by 5.27% and 4.76% respectively, with Chewy showing 100% buy order activity and a much longer typical hold time on Pluang of 68 days compared to 10 days for Smurfit WestRock.

More News

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
14 minutes ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
14 minutes ago
Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Kirby McInerney LLP is investigating NVE Corporation for possible violations of federal securities laws after the company reported a 47% revenue decline and a 33.7% stock price drop following its Q2 fiscal 2027 results. The revenue fall was attribute...

Market News
Bearish
2 hours ago
Fort Technology warned by Nasdaq for falling below $1 minimum bid price, given 180 days to comply.

Fort Technology warned by Nasdaq for falling below $1 minimum bid price, given 180 days to comply.

Fort Technology received a notification from Nasdaq on October 13, 2026, stating it failed to meet the minimum bid price requirement of $1.00 per share over the past 30 days. The company has 180 days, until April 12, 2027, to restore its share price ...

Market News
Bearish
3 hours ago
Global mobile battery market to nearly double to $45.95B by 2035 driven by lithium-ion demand and 5G growth

Global mobile battery market to nearly double to $45.95B by 2035 driven by lithium-ion demand and 5G growth

The global mobile battery market, valued at $24.9 billion in 2025, is projected to grow to $45.95 billion by 2035, driven by rising smartphone adoption, 5G rollout, and demand for longer-lasting, fast-charging batteries. Lithium-ion batteries dominat...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App